This page is part of the US Drug Formulary (v2.0.1: STU 2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
: Codes for medication drug tiers in health plans - JSON Representation
Raw json | Download
{
"resourceType" : "CodeSystem",
"id" : "usdf-DrugTierCS-TEMPORARY-TRIAL-USE",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">generic<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-generic\"> </a></td><td>Generic</td><td>Commonly prescribed generic drugs that cost more than drugs in the ‘preferred generic’ tier.</td></tr><tr><td style=\"white-space:nowrap\">preferred-generic<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-preferred-generic\"> </a></td><td>Preferred Generic</td><td>Commonly prescribed generic drugs.</td></tr><tr><td style=\"white-space:nowrap\">non-preferred-generic<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-non-preferred-generic\"> </a></td><td>Non-preferred Generic</td><td>Generic drugs that cost more than drugs in ‘generic’ tier.</td></tr><tr><td style=\"white-space:nowrap\">specialty<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-specialty\"> </a></td><td>Specialty</td><td>Drugs used to treat complex conditions like cancer and multiple sclerosis. They can be generic or brand name, and are typically the most expensive drugs on the formulary.</td></tr><tr><td style=\"white-space:nowrap\">brand<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-brand\"> </a></td><td>Brand</td><td>Brand name drugs that cost more than ‘preferred brand’ drugs.</td></tr><tr><td style=\"white-space:nowrap\">preferred-brand<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-preferred-brand\"> </a></td><td>Preferred Brand</td><td>Brand name drugs</td></tr><tr><td style=\"white-space:nowrap\">non-preferred-brand<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-non-preferred-brand\"> </a></td><td>Non-preferred Brand</td><td>Brand name drugs that cost more than ‘brand’ drugs.</td></tr><tr><td style=\"white-space:nowrap\">zero-cost-share-preventative<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-zero-cost-share-preventative\"> </a></td><td>Zero cost-share preventative</td><td>Preventive medications and products available at no cost.</td></tr><tr><td style=\"white-space:nowrap\">medical-service<a name=\"usdf-DrugTierCS-TEMPORARY-TRIAL-USE-medical-service\"> </a></td><td>Medical Service</td><td>Drugs that must be administered by a clinician or in a facility and may be covered under a medical benefit.</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "phx"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "trial-use",
"_valueCode" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/davinci-drug-formulary/ImplementationGuide/hl7.fhir.us.davinci-drug-formulary"
}
]
}
}
],
"url" : "http://hl7.org/fhir/us/davinci-drug-formulary/CodeSystem/usdf-DrugTierCS-TEMPORARY-TRIAL-USE",
"version" : "2.0.1",
"name" : "DrugTierCS",
"title" : "Codes for medication drug tiers in health plans",
"status" : "active",
"experimental" : false,
"date" : "2023-12-01T22:20:12+00:00",
"publisher" : "HL7 International / Pharmacy",
"contact" : [
{
"name" : "HL7 International / Pharmacy",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/medication"
},
{
"system" : "email",
"value" : "pharmacy@lists.HL7.org"
}
]
}
],
"description" : "Codes to represent the drug tier of a particular medication in a health plan. Base set are examples. Each plan may have its own controlled vocabulary.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"count" : 9,
"concept" : [
{
"code" : "generic",
"display" : "Generic",
"definition" : "Commonly prescribed generic drugs that cost more than drugs in the ‘preferred generic’ tier."
},
{
"code" : "preferred-generic",
"display" : "Preferred Generic",
"definition" : "Commonly prescribed generic drugs."
},
{
"code" : "non-preferred-generic",
"display" : "Non-preferred Generic",
"definition" : "Generic drugs that cost more than drugs in ‘generic’ tier."
},
{
"code" : "specialty",
"display" : "Specialty",
"definition" : "Drugs used to treat complex conditions like cancer and multiple sclerosis. They can be generic or brand name, and are typically the most expensive drugs on the formulary."
},
{
"code" : "brand",
"display" : "Brand",
"definition" : "Brand name drugs that cost more than ‘preferred brand’ drugs."
},
{
"code" : "preferred-brand",
"display" : "Preferred Brand",
"definition" : "Brand name drugs"
},
{
"code" : "non-preferred-brand",
"display" : "Non-preferred Brand",
"definition" : "Brand name drugs that cost more than ‘brand’ drugs."
},
{
"code" : "zero-cost-share-preventative",
"display" : "Zero cost-share preventative",
"definition" : "Preventive medications and products available at no cost."
},
{
"code" : "medical-service",
"display" : "Medical Service",
"definition" : "Drugs that must be administered by a clinician or in a facility and may be covered under a medical benefit."
}
]
}
|
Propose a change